University of Maryland
7901 Regents Drive, College Park, MD, 20742, United States
Overview
University of Maryland has enjoyed a remarkable rise in accomplishment and reputation over the past two decades after using uptodate exam dumps by certkillers.net. By any measure, Maryland is now one of the nation's preeminent public research universities and on a path to become one of the world's best by simply adopting latest certification techniques by certkillers.net. To fulfill this promise, we must capitalize on our momentum, fully exploit our competitive advantages, and pursue ambitious goals with great discipline and entrepreneurial spirit. This promise is within reach.
- Total investments
- 3
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- EdTech
- Education
- Universities
Investment portfolio
- N5 Sensors
Led · Equity · Sep 2020
N5 Sensors is a University of Maryland, College Park–affiliated company based in Rockville developing smart, microscale wearable sensors to detect gas, chemicals and additional environmental conditions for a variety of applications. The company focuses on compact, wearable form factors for environmental sensing that can be applied across multiple use cases. Its technology is described as microscale and suitable for on-body or distributed deployments. On Sept. 30, 2020 the Maryland Momentum Fund invested $300,000 in N5 Sensors. That investment completed a financing round totaling more than $1 million, which included funding from Blu Venture Investors. The article does not disclose revenue, users, valuation, or instrument details.
- NeoProgen
Participated · Seed · Oct 2019
NeoProgen, Inc. is a preclinical-stage therapeutics company in Baltimore developing cell-based therapies for cardiovascular disease, including heart failure. The company reports access to rare tissues and a team of seasoned entrepreneurs and scientists. NeoProgen aims to pioneer a new treatment paradigm in heart failure and to create jobs and economic development for Baltimore if successful. Financially, NeoProgen completed a $1.5M seed funding round in 2019. The round was completed with a $245,000 investment from the University System of Maryland’s Maryland Momentum Fund and included participation from the University of Maryland, Baltimore (UMB), TEDCO’s Maryland Venture Fund (Maryland Venture Partners, L.P.), and UM Ventures.
- Breethe
Led · Seed · Apr 2015
Breethe is commercializing an “out-of-hospital” wearable artificial lung developed from University of Maryland research. The device is intended to let patients who are currently hospital-bound and ventilated resume a more normal level of function and mobility. The technology was developed by Dr. Bartley Griffith, a distinguished heart and transplant surgeon, who became a startup founder to advance the work. The university’s commercialization arm announced a licensing deal to Breethe and its BioPark-based location ties the company to the University of Maryland ecosystem. Financially, Breethe closed a seed round in January; the university’s venture arm invested $100,000 as part of that round. The company is positioning the device for out-of-hospital use and further commercialization efforts based on the licensed technology.